부산대학교 도서관

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands. Electronic address: m.bloem@lumc.nl.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Simkens LHJ; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's-Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

van Dijk EJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. E.J.vandijk-9@umcutrecht.nl.; Nienhuis HH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Hartwig Medical Foundation, Amsterdam, Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center, Amsterdam, Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, Netherlands.; Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Nijmegen, Netherlands.; Kamphuis AM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Ros MM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Bos C; Department of Radiology and Nuclear Medicine, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Utrecht, Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard, Netherlands.; Blank CU; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands.; de Groot JWB; Isala Oncology Center, Isala Hospital, Isala, Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Breda, Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, Eindhoven, Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Nijmegen, Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands.; Haanen JB; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Janssen JC; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van Dijk B; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; de Joode K; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Aarts MJB; Department of Medical Oncology, Maastricht UMC+, Maastricht, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland MC, Sittard-Geleen, The Netherlands.; Blank CU; Department of Medical Oncology, NKI-AvL, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden UMC, Leiden, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; de Groot JWB; Department of Medical Oncology, Isala Zwolle, Zwolle, The Netherlands.; Jalving M; Department of Medical Oncology, UMC Groningen, Groningen, The Netherlands.; de Jonge MJA; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Joosse A; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden UMC, Leiden, The Netherlands.; Kamphuis-Huismans AM; Department of Medical Oncology, UMC Utrecht, Utrecht, The Netherlands.; Naipal KAT; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Piersma D; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, The Netherlands.; Rikhof B; Department of Medical Oncology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.; Westgeest HM; Department of Medical Oncology, Amphia Ziekenhuis, Breda, The Netherlands.; Vreugdenhil G; Department of Medical Oncology, Maxima Medisch Centrum Veldhoven, Veldhoven, The Netherlands.; Oomen-de Hoop E; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Mulder EEAP; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands. a.vanderveldt@erasmusmc.nl.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. a.vanderveldt@erasmusmc.nl.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

van der Veldt, A A M; Boven, E; Helgason, H H; van Wouwe, M; Berkhof, J; de Gast, G; Mallo, H; Tillier, C N; van den Eertwegh, A J M; Haanen, J B A G

British Journal of Cancer. 7/22/2008, Vol. 99 Issue 2, p259-265. 7p. 5 Charts, 2 Graphs.

Baars, A.; Claessen, A.M.E.; Wagstaff, J.; Giaccone, G.; Scheper, R.J.; Meijer, S.; Gall, H.E.; Vermorken, J.B.; Pinedo, H.M.; Schakel, M J A G; Meijer, C J L M; van den Eertwegh, A J M

British Journal of Cancer. 4/22/2002, Vol. 86 Issue 8, p1230-1234. 5p.

Borgers JSW; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Burgers FH; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schina A; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Van Not OJ; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Blank CU; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Sittard, The Netherlands.; de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.; Boer AMS; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Thienen JV; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JBAG; Department of Medical Oncology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands. Electronic address: m.bloem@lumc.nl.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands. m.bloem@lumc.nl.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands. m.bloem@lumc.nl.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.bloem@lumc.nl.; de Meza MM; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Centre, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard-Geleen, The Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Blokx WAM; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Bonenkamp JJ; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; de Groot JWB; Isala Oncology Centre, Isala, Zwolle, The Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; van Not OJ; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, Eindhoven, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Choueiri TK; The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu.; Penkov K; Private Medical Institution, Euromedservice, St. Petersburg, Russian Federation.; Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Japan.; Campbell MT; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Pal S; City of Hope, Duarte, USA.; Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, Canada.; Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Venugopal B; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.; van den Eertwegh AJM; Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Negrier S; University of Lyon, Centre Léon Bérard, Lyon, France.; Gurney H; Department of Clinical Medicine, Macquarie University, Sydney, Australia.; Albiges L; Institut Gustave Roussy, Villejuif, France.; Berger R; The Chaim Sheba Medical Center, Ramat Gan, Israel.; Haanen JBAG; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oyervides Juárez V; Hospital Universitario Dr. Jose Eleuterio Gonzalez, Centro Universitario Contra el Cancer, Monterrey, Mexico.; Rini BI; Vanderbilt-Ingram Cancer Center, Nashville, USA.; Larkin J; Royal Marsden NHS Foundation Trust, London, UK.; Nolè F; Istituto Europeo di Oncologia, Milan, Italy.; Schmidinger M; Medical University of Vienna, Vienna, Austria.; Atkins MB; Georgetown University Medical Center, Washington, USA.; Tomita Y; Department of Urology, Niigata University Graduate School of Medicine, Niigata, Japan; Department of Molecular Oncology, Niigata University Graduate School of Medicine, Niigata, Japan.; Ellers-Lenz B; Merck Healthcare KGaA, Darmstadt, Germany.; Hoffman J; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, USA.; Sandner R; Pfizer, Collegeville, USA.; Wang J; Pfizer, Cambridge, USA.; di Pietro A; Pfizer srl, Milan, Italy.; Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: motzerr@MSKCC.ORG.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Özkan A; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; van den Bos F; Department of Gerontology and Geriatrics, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Bloem M; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Haanen JB; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Holtslag CE; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, s-Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, De Run 4600, Eindhoven 5504DB, the Netherlands.; Wouters MWJM; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands.; Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; de Glas NA; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands; Department of Medical Oncology, Helse Førde, Svanehaugvegen 2, Førde 6812, Norway. Electronic address: N.A.de_Glas@lumc.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE; PubMed not MEDLINE

Özkan A; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; van den Bos F; Department of Gerontology and Geriatrics, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Bloem M; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Haanen JB; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Holtslag CE; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, 's-Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, De Run 4600, Eindhoven 5504DB, the Netherlands.; Wouters MWJM; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands.; Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; de Glas NA; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands; Department of Medical Oncology, Helse Førde, Svanehaugvegen 2, 6812 Førde, Norway. Electronic address: N.A.de_Glas@lumc.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Haanen JBAG; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Blank CU; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, The Netherlands.; de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van der Veldt AAM; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Mulder EEAP; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.; Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.; de Joode K; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.; Litière S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht Cancer Centre, Utrecht, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands.; de Groot JWB; Department of Medical Oncology, Isala Oncological Centre, Zwolle, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Centre - location VU, Amsterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, Maastricht University Medical Centre +, Maastricht, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.; Vreugdenhil G; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands.; van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.; Hoop EO; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.; Franken MG; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Ryll B; Melanoma Patient Network Europe, Uppsala, Sweden.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Sleijfer S; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands. a.vanderveldt@erasmusmc.nl.; Department of Radiology & Nuclear Medicine, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands. a.vanderveldt@erasmusmc.nl.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Franken MG; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: franken@imta.eur.nl.; Leeneman B; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.; van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.; de Groot JWB; Oncology Center Isala, Isala, Zwolle, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands. hwestgeest@amphia.nl.; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands. hwestgeest@amphia.nl.; Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.; de Wit R; Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.; Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; van Moorselaar RJA; Department of Urology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.; Coenen JLLM; Department of Internal Medicine, Isala Klinieken, Zwolle, the Netherlands.; van den Bergh ACM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands.; Somford DM; Department of Urology, Canisius Wilhemina Hospital, Nijmegen, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.; Aben KKH; Department for Health Evidence, Radboud University Medical Center, The Netherlands and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

van Zeijl MCT; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden, 2333AA, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333ZA, the Netherlands.; de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, Leiden, 2333ZC, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, Location VU Medical Center (VUmc), Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, the Netherlands.; Wouters MWJM; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden, 2333AA, the Netherlands; Department of Surgical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066CX, the Netherlands.; Jochems A; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden, 2333AA, the Netherlands; Department of Medical Oncology, Haaglanden Medisch Centrum, Lijnbaan 32, Den Haag, 2512VA, the Netherlands.; Schouwenburg MG; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden, 2333AA, the Netherlands.; Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, P. Debyelaan 25, Maastricht, 6229 HX, the Netherlands.; van Akkooi ACJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066CX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Dr. H. van der Hoffplein 1, Sittard-Geleen, 6162BG, the Netherlands.; de Groot JWB; Department of Medical Oncology, Isala Clinics, Dokter van Heesweg 2, Zwolle, 8025AB, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333ZA, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede, 7512KZ, the Netherlands.; van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Henri Dunantweg 2, Leeuwarden, 8934AD, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Cancer Center, Heidelberglaan 100, Utrecht, 3584CX, the Netherlands.; Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda, 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, Rotterdam, 3015CE, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, De Run 4600, Eindhoven, 5504DB, the Netherlands.; van der Hoeven JJM; Department of Medical Oncology, Radboudumc, Geert Grooteplein Zuid 10, Nijmegen, 6525GA, the Netherlands.; Haanen JBAG; Divisions of Medical Oncology and Molecular Oncology & Immunology, the Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066CX, the Netherlands. Electronic address: j.haanen@nki.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

van der Veldt AA; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands.; Meijerink MR; van den Eertwegh AJ; Haanen JB; Boven E

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Pentinga SE; Bruining HG; Gerritsen WR; van den Eertwegh AJ; Rustemeyer T

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

van Cruijsen H; Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. h.vancruijsen@vumc.nl; Hoekman K; Stam AG; van den Eertwegh AJ; Kuenen BC; Scheper RJ; Giaccone G; de Gruijl TD

Publisher: Hindawi Pub. Corporation Country of Publication: Egypt NLM ID: 101183692 Publication Model: Print Cited Medium: Internet ISSN: 1740-2530 (Electronic) Linking ISSN: 17402522 NLM ISO Abbreviation: Clin Dev Immunol Subsets: MEDLINE

Haanen JB; Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, Amsterdam, The Netherlands.; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE